Literature DB >> 17849729

Current management of rheumatoid arthritis.

Siddharth Tambar1, Eric M Ruderman.   

Abstract

Rheumatoid arthritis (RA), the most common form of inflammatory arthritis, is a chronic, inflammatory, progressive disease. Most patients have moderate disease, with a variable disease course and symptomatic flares interspersed with periods of relatively lower disease activity. Over the last 2 decades, the treatment of RA has evolved dramatically, from use of disease-modifying antirheumatic drugs to newer biologics. None of these therapies represents a cure for RA; however, the availability and the efficacy of multiple treatments has made remission of the disease a realistic target.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17849729

Source DB:  PubMed          Journal:  Manag Care Interface        ISSN: 1096-5645


  2 in total

1.  Water-soluble fullerene (C60) inhibits the development of arthritis in the rat model of arthritis.

Authors:  Kazuo Yudoh; Rie Karasawa; Kayo Masuko; Tomohiro Kato
Journal:  Int J Nanomedicine       Date:  2009-10-19

2.  Interactions among Low Dose of Methotrexate and Drugs Used in the Treatment of Rheumatoid Arthritis.

Authors:  Marinella Patanè; Miriam Ciriaco; Serafina Chimirri; Francesco Ursini; Saverio Naty; Rosa Daniela Grembiale; Luca Gallelli; Giovambattista De Sarro; Emilio Russo
Journal:  Adv Pharmacol Sci       Date:  2013-05-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.